Restrictions for patents owners to preserve the public interest in the sufficient availability of necessary medicinal products
GDPR and life sciences – part 2
The Bolar and related exemptions in Europe
What activity do they cover?
作者
Falsified Medicine Directive continued: Safety features on medicinal products and its consequences
National perspectives on the CJEU Bayer decision
作者
Synapse - December 2019
作者
First Dutch GDPR fine for failing to ensure security of patient files
Dr Bill Frankland: Penicillin, the pollen count and perspectives on medicine